Rexulti® vs Abilify®: Which is Right for You?

Welcome to our comprehensive comparison of two widely used antipsychotic medications, Rexulti and Abilify. If you or a loved one is navigating the treatment of mental health conditions such as schizophrenia, major depressive disorder, or bipolar disorder, it's essential to understand the differences, similarities, and key factors to consider when choosing between these extended-release medications. This blog will delve into the active ingredients, uses, side effects, efficacy, cost, patient experiences, and ultimately, how to make the right medication decision. By the end, you'll be equipped with the knowledge to have an informed discussion with your healthcare provider and make a well-informed choice for your mental health journey. So, let's dive in and explore the world of Rexulti and Abilify!

Key Takeaways

  • Both Rexulti and Abilify are atypical antipsychotics. This means they are newer medications with lower general rates of side effects compared with older, ‘typical’ antipsychotics.
  • They are both approved for the management of schizophrenia and adjunct (along with an antidepressant) therapy for depression.
  • Abilify has a more established history of use for bipolar disorder, autism, and Tourette’s disorder.
  • Abilify is available in several forms (standard tablets, disintegrating tablets, liquid, and long-acting injectables), while Rexulti is available only in standard tablet form.
  • Abilify has generics available, while Rexulti is brand-only. This can significantly affect insurance coverage and price.
  • Abilify appears more likely to cause restlessness, insomnia, and nausea.
  • Both medications appear equally likely to cause mild weight gain. This weight gain has generally been less compared with other antipsychotic medications.
  • Both medications are affected by CYP3A4 and CYP2D6 enzyme activity. They have similar drug interactions and the potential for individual genetic variability in responses.

Understanding Rexulti and Abilify

Before we explore the specific details of Rexulti and Abilify, let's take a moment to understand what they are and how they play a crucial role in the treatment of mental health conditions. Both Rexulti and Abilify belong to a class of medication known as atypical antipsychotics. These medications are commonly prescribed to manage symptoms of schizophrenia, major depressive disorder, bipolar disorder, and other mental health conditions. By targeting specific neurotransmitters in the brain, atypical antipsychotics aim to regulate mood, cognition, and behavior.

Overview of Rexulti

Rexulti, with the generic name brexpiprazole, is an atypical antipsychotic medication approved by the United States Food and Drug Administration (FDA) for the treatment of schizophrenia and major depressive disorder. It is available in tablet form for oral use. Rexulti acts as a partial agonist at dopamine receptors, which means it can both stimulate and block the activity of dopamine, a neurotransmitter involved in mood regulation. By modulating dopamine activity, Rexulti helps restore the balance of chemicals in the brain.

Overview of Abilify

Abilify, generic name aripiprazole, is another atypical antipsychotic medication commonly prescribed for a range of mental health conditions, including schizophrenia, bipolar disorder, major depressive disorder, and others. Unlike Rexulti, Abilify is available in both tablet form and oral solution, providing options for different administration methods. Similar to Rexulti, Abilify also works by modulating dopamine activity, but it differs in its mechanism of action, specific drug interactions, and side effect profile. It is important to note that under the brand name Abilify Maintena, the medication is also available as a long-acting injectable form for the maintenance treatment of schizophrenia.

Ready to finally find the right medication?
Compare Tests trusted-by

Key Differences Between Rexulti and Abilify

While Rexulti and Abilify belong to the same class of atypical antipsychotics and share some similarities, it's important to highlight the key differences between them. These differences include their active ingredients, uses, forms, administration methods, drug interactions, side effects, efficacy, cost, and availability of generic versions. Understanding these distinctions, along with their classification as a group of drugs called atypical antipsychotics, can help you and your healthcare provider make a more informed decision about which medication may be most suitable for your specific needs and condition.

Active ingredients

One critical difference between Rexulti and Abilify lies in their active ingredients. Rexulti contains brexpiprazole, while Abilify contains aripiprazole in its generic form. Despite their different chemical compositions, both drugs belong to the same class of antipsychotic medications, atypical antipsychotics, and have similar effects on the brain. The specific active ingredients, brexpiprazole and aripiprazole, have been extensively studied and proven effective in treating mental health conditions.

Healthcare providers consider each medication's unique characteristics when prescribing them to patients, considering factors such as efficacy, side effect profile, drug interactions, and patient preferences.

  • Both Rexulti (brexpiprazole) and Abilify (aripiprazole) belong to the class of atypical antipsychotic medications. These drugs work by modulating the activity of dopamine, a neurotransmitter involved in mood, pleasure, and motivation, among other functions. While both medications share a common mechanism of action, their specific interactions with dopamine receptors may differ, resulting in varying clinical effects.
  • Brexpiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, stimulating and blocking these receptors to varying degrees. Its partial agonist activity at dopamine receptors is believed to help rebalance dopamine levels in the brain, alleviating symptoms of schizophrenia and major depressive disorder. Additionally, brexpiprazole may also exert effects at other receptor sites, such as serotonin 5-HT2A and noradrenaline α1B receptors.
  • On the other hand, aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, similar to brexpiprazole. However, aripiprazole is also a partial agonist at serotonin 5-HT2A receptors. This receptor activity may contribute to aripiprazole's antidepressant effects, as serotonin is involved in mood regulation. The mechanism of action of aripiprazole makes it a multitarget drug, impacting multiple receptor systems implicated in mental health disorders.
  • It is worth noting that while both drugs function as partial agonists at dopamine and serotonin receptors, the specific binding affinities and receptor activation profiles of brexpiprazole and aripiprazole differ, leading to some differentiation in clinical effects. Healthcare providers prescribe these drugs based on their understanding of the receptor interactions, individual patient needs, and evidence from clinical trials.
  • Clinical studies comparing the efficacy and side effect profiles of brexpiprazole and aripiprazole have been conducted for specific mental health conditions, providing healthcare providers with valuable information when prescribing these medications. Carefully considering the active ingredients allows healthcare providers to make informed decisions and tailor treatment plans to each patient's unique requirements.

Uses and indications

Rexulti and Abilify have specific FDA-approved uses and indications based on evidence from clinical trials and prescribing information provided by drug manufacturers. Let's take a closer look at the uses and indications for each medication:

Rexulti:

  • FDA-approved uses: Treatment of schizophrenia and adjunctive treatment of major depressive disorder.
  • Adjunctive treatment: In combination with antidepressant medication, Rexulti can improve symptoms of major depressive disorder beyond what antidepressant medication alone may achieve.
  • Treatment plan: Rexulti is a part of a treatment plan that includes counseling, therapy, or other non-pharmacological interventions.
  • Prescribing information: It is important to review Rexulti's prescribing information to fully understand its approved uses, dosage, administration, and potential drug interactions.

Abilify:

  • FDA-approved uses: Abilify has multiple approved uses, including the treatment of schizophrenia, bipolar disorder, major depressive disorder, and adjunctive treatment for major depressive disorder.
  • Bipolar disorder: Abilify can be used as a standalone treatment for manic episodes or as an adjunctive treatment with other mood stabilizers.
  • Treatment plan: Similar to Rexulti, Abilify is often prescribed as part of a comprehensive treatment plan that may include counseling, therapy, or other interventions.
  • Prescribing information: Familiarizing yourself with the prescribing information of Abilify is crucial for understanding its approved uses, recommended dosage, administration, and potential drug interactions.

Forms and administration methods

Rexulti and Abilify are available in different forms and administration methods, providing flexibility for healthcare providers to choose the most suitable option for each patient's needs. Let's explore the various forms and administration methods of Rexulti and Abilify:

Rexulti:

  • Tablet form: Rexulti is available in tablet form, which allows for oral administration. Tablets can be easily swallowed with a glass of water and taken with or without food, as directed by the prescribing physician.
  • Extended-release: Rexulti tablets are formulated as extended-release, meaning the medication is released gradually over time, ensuring a steady blood concentration of the drug and potentially reducing side effects associated with rapid changes in drug levels.

Abilify:

  • Tablet form: Abilify is available as tablets, similar to Rexulti. These tablets can be taken orally, with or without food, as prescribed by the healthcare provider.
  • Oral solution: In addition to tablets, Abilify is available in oral solution form. The oral solution offers an alternative administration method, especially for individuals who may have difficulty swallowing tablets.
  • Dissolving Tablets: Orally disintegrating tablets provide another option for those with difficulty swallowing standard tablets.
  • Long-acting injectable: Abilify is also available in an injectable form known as Abilify Maintena. This is generally administered intramuscularly once per month.
  • By offering different forms and administration methods, healthcare providers can consider individual patient preferences, specific needs, and any challenges patients may face when taking medication. It is essential to follow the healthcare provider's instructions regarding the appropriate form, administration method, dosage, and timing of medication intake, as outlined in the prescribing information of both Rexulti and Abilify.

Similarities Between Rexulti and Abilify

While there are important differences between Rexulti and Abilify, they also share certain similarities. Understanding the commonalities can provide a broader perspective on their mechanisms of action, class of drugs, and FDA-approved uses. Here are a few key similarities between Rexulti and Abilify:

  • Drug class and mechanism of action: Both Rexulti and Abilify belong to the class of atypical antipsychotic medications and work by modulating dopamine activity, aiming to restore balance in the brain and improve symptoms of mental health conditions.
  • FDA-approved uses: Both medications have received FDA approval for specific mental health conditions, providing healthcare providers and patients with assurance of their efficacy and safety profiles.
  • Treatment of schizophrenia: Rexulti and Abilify are both approved for the treatment of schizophrenia, a serious mental illness characterized by hallucinations, delusions, disorganized thinking, and other symptoms.
  • Both medications are also approved for adjunctive (combined with other therapeutic options) management of depression.

Drug class and mechanism of action

One of the important similarities between Rexulti and Abilify is their shared drug class, atypical antipsychotics, and mechanism of action, specifically targeting dopamine receptors in the brain. Let's take a closer look at the drug class, mechanism of action, and receptor interactions for these medications.

Atypical antipsychotic class:

  • Atypical antipsychotics, including Rexulti and Abilify, are a class of medication commonly prescribed for the treatment of mental health conditions such as schizophrenia, bipolar disorder, major depressive disorder, and others.
  • Compared to older, typical antipsychotic medications, atypical antipsychotics offer a more diverse receptor profile, impacting multiple neurotransmitter systems, which may contribute to their efficacy and improved side effect profile.
  • The class of atypical antipsychotics emerged as a result of ongoing research and development, driven by a desire to develop medications that effectively target symptoms of mental health disorders with a reduced risk of side effects associated with older, ‘typical’ antipsychotic drugs.

Mechanism of action:

  • The mechanism of action of atypical antipsychotics, including Rexulti and Abilify, revolves around dopamine receptors in the brain. Dopamine is a neurotransmitter involved in various functions, including mood regulation, pleasure, motivation, and movement coordination.
  • Rexulti, a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, helps rebalance dopamine activity by both stimulating and blocking these receptors to varying degrees. This partial agonist activity allows for a more nuanced and targeted effect within specific brain circuits, potentially reducing side effects associated with a full agonist or antagonist activity.
  • Similarly, Abilify also acts as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors. However, Abilify is also a partial agonist at serotonin 5-HT2A receptors, which may contribute to its antidepressant effects, as serotonin is involved in mood regulation.

Healthcare professionals leverage their understanding of the drug class and mechanism of action of atypical antipsychotics, like Rexulti and Abilify, to develop treatment plans, select appropriate medication options, and optimize treatment outcomes for patients with mental health conditions.

FDA-approved uses

The FDA has approved Rexulti and Abilify for specific mental health conditions, providing healthcare providers and patients with a guideline for their appropriate use. Let's explore the FDA-approved uses of both medications:

Rexulti:

  • Schizophrenia: Rexulti is FDA-approved for the treatment of schizophrenia, a mental disorder characterized by symptoms such as hallucinations, delusions, disorganized thinking, and a reduced ability to function in daily life.
  • Major depressive disorder (MDD): Rexulti is also approved as an adjunctive treatment for major depressive disorder, a mood disorder characterized by persistent feelings of sadness, loss of interest, changes in appetite, sleep disturbances, and a lack of energy.
  • Adjunctive treatment: When used adjunctively, Rexulti is prescribed alongside an antidepressant medication. This combination therapy aims to enhance the efficacy of antidepressants, especially in patients who have had a partial response to antidepressant monotherapy.
  • Treatment of patients: Rexulti is typically prescribed by healthcare providers specializing in mental health, including psychiatrists, psychiatric nurse practitioners, and other professionals experienced in the treatment of patients with schizophrenia or major depressive disorder.
  • Prescribing information: It's important to review the prescribing information of Rexulti for a comprehensive understanding of its approved uses, dosage, administration, duration of treatment, and potential drug interactions.

Abilify:

  • Schizophrenia: Similar to Rexulti, Abilify is approved by the FDA for the treatment of schizophrenia, with a focus on managing symptoms such as hallucinations, delusions, disorganized thinking, and a reduced ability to function socially.
  • Bipolar disorder: Abilify is also approved for the treatment of bipolar disorder, a mood disorder characterized by episodes of mania and depression. Abilify may be prescribed as a standalone treatment for manic episodes or as an adjunctive treatment with other mood stabilizers to manage symptoms of bipolar disorder.
  • Major depressive disorder (MDD): Furthermore, Abilify is indicated as an adjunctive treatment for major depressive disorder, helping to alleviate symptoms of depression when used alongside antidepressant medication.
  • Treatment of patients: Similar to Rexulti, the prescribing of Abilify is typically done by healthcare providers with expertise in mental health, such as psychiatrists, psychiatric nurse practitioners, and other professionals specializing in the treatment of patients with schizophrenia, bipolar disorder, or major depressive disorder.
  • Prescribing information: Familiarizing yourself with Abilify's prescribing information is crucial for understanding its approved uses, recommended dosage, administration, duration of treatment, and potential drug interactions.

By evaluating the FDA-approved uses of Rexulti and Abilify, healthcare providers can align treatment decisions with clinical guidelines, ensuring patients receive the most appropriate medication options for their specific mental health conditions.

Side Effects: Rexulti vs. Abilify

Comparing the side effects of Rexulti and Abilify is crucial for informed decision-making. Both medications share common side effects, such as weight gain, dyskinesia, and restlessness. However, noteworthy differences exist; Abilify may cause more restlessness and insomnia.

When evaluating the risk of potential side effects, individual factors, including age, medical history, and concurrent medications, must be considered. Monitoring for adverse effects like tardive dyskinesia or neuroleptic malignant syndrome is imperative during treatment with either medication. Consulting a healthcare professional for guidance on managing side effects can enhance the therapeutic journey.

Both medications can be affected by variability in CYP3A4 and CYP2D6 enzyme activity. These enzymes affect how quickly the medications are metabolized. If you take other medications that affect these enzymes or if you produce more or less of these enzymes because of your individual genetics, it can affect how well the medications work or how likely they will be to cause side effects. Dosage adjustments may be needed based on these factors.

Common side effects of Rexulti

The most common side effects associated with Rexulti include:

  • Akathisia (restlessness or an inability to sit still).
  • Headache.
  • Somnolence (drowsiness).
  • Dyskinesia (involuntary movements like tremors).
  • Mild weight gain.

Both Rexulti and Abilify are associated with weight gain. However, this has generally been less significant than with other medications in this class. Rexulti and Abilify appear to cause roughly the same amount of weight gain when compared side by side.

Common side effects of Abilify

The most common side effects associated with Abilify include:

  • Akathisia (restlessness or an inability to sit still).
  • Insomnia.
  • Somnolence (drowsiness).
  • Nausea.
  • Dyskinesia (involuntary movements like tremors).
  • Blurred vision.
  • Mild weight gain.

When compared side by side with Rexulti, Abilify appears more likely to cause restlessness, insomnia, and nausea.

If you notice any concerning side effects, consult a healthcare professional for guidance on managing them effectively.

Serious side effects and precautions

Treatment with medications like Rexulti and Abilify has been associated with suicidal thoughts and behaviors. The conditions this medication is used to treat are also associated with these thoughts and actions. Support is critical if you or a loved one are experiencing a crisis. National programs are available 24 hours a day, seven days a week by dialing 988 or visiting 988lifeline.org.

Efficacy of Rexulti vs. Abilify

When comparing the efficacy of Rexulti and Abilify, it's essential to consider their effectiveness in treating schizophrenia and major depressive disorder. Both medications belong to the same class of drugs and act on serotonin receptors, showing similar effects in managing these conditions.

Studies have indicated that both Rexulti and Abilify can be effective in alleviating symptoms associated with schizophrenia and major depressive disorder. When developing a treatment plan, the expertise of a licensed healthcare provider is crucial to determine the most suitable medication based on an individual's specific needs and medical history.

Effectiveness in treating schizophrenia

Both Rexulti and Abilify exhibit efficacy in managing schizophrenia symptoms. From a practical standpoint, the additional forms of Abilify available (i.e., once-monthly injections, liquids, and dissolvable tablets) may provide improved accessibility to treatment.

Effectiveness in treating major depressive disorder

In managing major depressive disorder, Rexulti demonstrates effectiveness by effectively treating symptoms and aiding in depression management. Similarly, Abilify is utilized for treating this condition, showcasing efficacy in symptom control for major depression. Both medications play a crucial role in addressing depressive episodes and managing the challenges associated with this mental health condition.

Neither Abilify nor Rexulti appear to be significantly superior for managing depression. When considering which medication to choose for treating major depressive disorder, understanding the individual response and potential benefits under the guidance of a healthcare professional is vital to tailoring the treatment plan effectively.

Cost Comparison: Rexulti vs. Abilify

When comparing the costs of Rexulti and Abilify, it's essential to evaluate insurance coverage and affordability factors. At this time, Rexulti is available as a brand-name-only formulation, while Abilify has generic versions. This can impact insurance coverage and out-of-pocket expenses.

Exploring how one's insurance plan covers each drug can be crucial in decision-making. Additionally, consulting with a licensed healthcare provider about cost-effective treatment options can help manage expenses associated with these medications. It's vital to consider the financial aspect in conjunction with the effectiveness of the treatment plan to make an informed decision on which medication best suits individual needs.

Patient Experiences with Rexulti and Abilify

Patient experiences with Rexulti and Abilify often vary, highlighting the importance of individual responses to these medications. Users have reported diverse outcomes, emphasizing the need for a personalized treatment plan. Understanding the nuances of how each medication affects different individuals can help optimize mental health management.

From reviews and ratings, it is evident that patient advice on managing side effects plays a crucial role in enhancing treatment adherence and overall well-being. By sharing experiences and insights, individuals can contribute to a better understanding of the practical aspects of using these medications in real-world scenarios. For those who have difficulty swallowing tablets,

Reviews and ratings from users

Based on user feedback and experiences, Rexulti and Abilify have garnered mixed reviews. While some users praise the effectiveness of both medications in managing their conditions, others report experiencing troubling side effects. Users offer diverse opinions and assessments regarding the suitability of this combination for their respective needs.

Evaluations from individuals with firsthand experience with Rexulti and Abilify highlight the importance of consulting healthcare professionals to determine the most appropriate treatment plan. Each person's journey with this drug combination can differ, emphasizing the need for personalized care in navigating the complexities of mental health treatment.

Patient advice on side effects management

Both medications have the potential to cause involuntary movement. This can be experienced as tremors or shaking in hands, sudden jerky movements in arms or legs, or other involuntary movements. If these occur, it’s important to consult your healthcare provider. Treatment is available to help limit these side effects if it’s determined the medication should be continued. Your provider may also suggest switching to an alternative.

Weight management is a common concern among individuals using these medications. While they are less likely to cause significant weight gain compared with similar treatment options, some weight gain is still possible. Many strategies can be employed to combat this, ranging from diet and exercise to additional medications for weight management. If you have concerns about your weight, it’s important to discuss them so a personalized plan can be implemented.

Making the Choice: Rexulti or Abilify?

The primary potential differences between the medications include:

  • Conditions they are more commonly used for (i.e., Abilify is more established for bipolar disorder, autism, or Tourette’s).
  • Side effects they may cause.
  • Insurance coverage and cost.

How to determine which medication is right for you?

Consider the history of use for each medication and your individual needs, and consult your doctor about any concerns you have related to therapy. For instance, if you are concerned about insomnia, it may impact your decision. It’s also helpful to contact your insurance company to see what level of coverage may be expected for each option.

Conclusion

In conclusion, choosing between Rexulti and Abilify requires careful consideration of their key differences in active ingredients, uses, and side effects. While both medications have similarities in drug class and FDA-approved uses, individual efficacy, cost, and patient preferences play crucial roles in the decision-making process. It is essential to consult with your healthcare provider to determine the most suitable option based on your specific medical needs and considerations. Understanding the nuances of each medication and how they align with your treatment goals will guide you toward making an informed decision for your mental health journey.


Refrences:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305164/

https://www.medicalnewstoday.com/articles/atypical-antipsychotics

https://clinicaltrials.gov/ct2/show/NCT04174365

https://www.researchgate.net/publication/355336034_A_double-blind_placebo-controlled_study_of_brexpiprazole_in_the_treatment_of_borderline_personality_disorder

https://pubmed.ncbi.nlm.nih.gov/31613519/

https://journals.sagepub.com/doi/abs/10.1177/1039856217732473

https://link.springer.com/article/10.1007/s00213-020-05472-5

https://psychscenehub.com/psychinsights/brexpiprazole-psychopharmacology/

https://pubmed.ncbi.nlm.nih.gov/20008446/

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d301358-6291-4ec1-bd87-37b4ad9bd850

Compare medications reported in ClarityX